© 2020 MJH Life Sciences and Rheumatology Network. All rights reserved.
November 29, 2016
Good early management of pulmonary hypertension in patients with systemic sclerosis leads to better outcomes and fewer complications, researchers report.
November 28, 2016
Systemic sclerosis patients with pulmonary hypertension and heart dysfunction are more likely to succumb from scleroderma-related causes, researchers report.
October 07, 2016
In this slideshow, we summarize the difference between primary and secondary Raynaud’s phenomenon and recommended treatments.
October 05, 2016
The onset of Raynaud's phenomenon at 40 years could predict whether a connective tissue disease will develop.
May 31, 2016
The next Rheumatology Journal Club Twitter chat will be from 4-5 p.m. and 10-11 p.m. EST, June 2. The chat will focus on tocilizumab for systemic sclerosis.
January 06, 2016
Lung scarring early in systemic scleroderma can reduce lung function and leave patients gasping for breath. New treatments show promise.
November 08, 2015
Patients with systemic sclerosis who take cyclophosphamide or mycophenolate mofitil experience a decrease in lung scarring.
September 23, 2015
A Clinical and Experimental Rheumatology review offers a critical analysis of recent studies on systemic sclerosis to best classify and manage this chronic condition.
July 27, 2015
Patients diagnosed with systemic sclerosis (SSc) may have a three times greater risk of venous thromboembolism (VTE) – including potentially deadly clots in the lungs – and an increased risk in the first year after a diagnosis.
June 05, 2015
Hardening of the skin in systemic sclerosis impairs patients' ability to care for their own teeth properly. As a result, this study suggests, dental issues may be prognostic indicators.